Over the last two decades, advances in the field of cancer genetics have given patients and their healthcare providers the opportunity to determine increased predisposition to certain cancers. New genetic discoveries are influencing our understanding of cancer development, diagnosis and treatment.
As part of our mission to provide comprehensive and quality cancer care, the Lipson Institute for Cancer and Blood Disorders provides individualized cancer risk assessment and genetic testing services to individuals and families who are at increased risk for cancer. Identifying these at-risk individuals and groups enables Lipson team members to perform personalized medical management interventions that foster early cancer detection and even prevention, and improved quality of life for patients and their families.
The goal of the program is to prevent cancer or, should cancer occur, to detect it as early as possible by identifying individuals at increased risk by:
- Conducting a comprehensive cancer-specific genetic evaluation, including a review of family history and risk assessment
- Performing psychosocial assessments and counseling regarding the risks, limitations, and benefits of genetic testing
- Providing education regarding suspected hereditary cancer syndromes, including cancer risks associated with gene mutations, basic genetic concepts, inheritance patterns and concepts of penetrance and variable expressivity.
- Coordinating genetic testing through certified laboratories and provide interdisciplinary collaborations with oncologists and other specialists
- Disclosing test results during a formal post-test counseling session, with an explanation of the significance and implications of genetic test results, medical management options and family member relevance
- Outlining risk-reduction options and referrals for high-risk patients to the appropriate clinical services
- Offering up-to-date information on cancer-related research opportunities
At the Lipson Institute for Cancer and Blood Disorders, our clinical teams devote their advanced expertise in cancer genetics to the identification, testing and counseling of at-risk patients. Our hereditary cancer risk assessment program is an important part of our commitment to providing world-class oncology services to our patients and community.
To learn more, call 585.922.4020.